The use of antibiotics in Italy: National Report - Year 2020

On 10 March 2022, the National Report on the use of antibiotics in Italy -2020', concerning antibiotics for human use, was presented on AIFA's YouTube channel to monitor consumption and expenditure trends in Italy and identify areas of potential inappropriate use.

A morning of intense work in which we participated with interest.
We have produced a summary in graphic format with the highlights that seem to us most relevant to the governance of this type of drug.

In particular, the Report shows that:

- 3 out of 10 citizens received at least one antibiotic prescription in 2020. Utilisation is highest in the paediatric segment and in the over-80s.
- In 2020, antibiotics accounted for 1.2% of consumption and 3% of SSN expenditure (692 million) in Italy. Overall consumption is decreasing (-18.2%), but higher than the European average.
- Prices that are too low can be an incentive to buy: we need to think about policies on new antibiotics or separating price from industry revenues or find new ways to approach this aspect that has contributed to widespread use.

Why it is important to ask the right questions

This is the opening speech by Valeria Viola at the SIF - SIARV - SIMEF course, Medicines: regulatory tools I thank SIF, SIARV and

AIFA GUIDELINES - Our comments

On 30 September 2020, we sent to AIFA's dedicated email address our comments on the 'Guidelines for the compilation of the Dossier supporting the

LEA Commission

With the Ministerial Decree of 5/5/2020, the new National Commission for the updating of the Essential Levels of Care (LEA) was established. The commission remains in office for three